A teenage girl presented to the hospital emergency department with a three-week history of intermittent frontal headache, which was worse in the morning and associated with nausea, vomiting, lethargy, ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Eye problems are common for many people. Whether it is changes in your vision prompting new glasses or sore, tired eyes at the end of a long day most are common and not sinister. However there are ...

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for ...

Optic disk swelling is noted in approximately one-third of patients. The term papillitis is used to describe inflammatory disk swelling that is concentrated at the optic nerve head. Hemorrhages ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

There are several well-known signs of a brain tumour such as headaches and seizures but one little-known symptom comes and goes in seconds ...

Objectives: To investigate the prevalence of ocular injuries in a large population of boxers over a period of 16 years, in particular, the most severe lesions that may be vision threatening. Methods: ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...